HighVista Strategies »

Yandex Nv-a shares owned by HighVista Strategies

Quarter-by-quarter ownership of Yandex Nv-a (NBIS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Yandex Nv-a

Tip: Access up to 7 years of quarterly data

All positions including Yandex Nv-a held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Yandex Nv-a by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $584k 5.2k 112.27
2018-09-30 $668k 20k 32.91

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Yandex Nv-a

Tudor Investment Corporation
Orbis Allan Gray
Susquehanna International
Citadel Advisors
Fred Alger Management
Jane Street
Wells Fargo & Company
Jericho Capital Asset Management
Accel Leaders 4 Associates
Altshuler Shaham
UBS Group
Millennium Management
Invesco
Two Sigma Investments
Two Sigma Advisers

View all funds holding Yandex Nv-a